期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

美国对药品专利技术政策国际协调的回应策略

The U.S.A.Response Strategy to the International Coordination of Drug Patent Technology Policy
下载PDF
导出
摘要 《TRIPs协议修正案》的出台标志着药品专利技术政策国际协调的新成果。作为一种回应措施,美国纷纷签署一些自由贸易协定。这些协定未能重申药品专利政策国际协调成果中的重要原则和标准,扩大可专利种类和范围,明确否认《修正案》平行进口,限制《修正案》强制许可制度和措施,增加许多新条款应对《修正案》,延长专利期限。 The creation of the TRIPs Amendments symbols the new results of the international coordination of the drug patent technology policy. As a response, the America promotes signing some Extra TRIPs Agreements. These Agreements does not stress the principles and standards stat ed in both TRIPs and its Amendments. The Extra TRIPs Agreements have broadened the patentable types of the TRIPs, rejecting parallel import and limiting compulsory license regulated in the TRIPs Amendments, raising some new articles to meet the creation of the TRIPs Amendments, and prolonging patent time.
作者 熊建军
机构地区 福建工程学院法学院
出处 《科技和产业》 2013年第9期98-103,150,共7页 Science Technology and Industry
关键词 TRIPs协议修正案 自由贸易协定 专利技术政策 药品 TRIPs amendments free trade agreements patent technology policy drug
分类号 F744 [经济管理—国际贸易]
  • 相关文献

参考文献19

  • 1World Trade Organization. Ministerial Declaration of 14 No- vember 2001. International Legal Materials[J]. 2002, 41: 746.
  • 2MSF Access to Medicines Campaign. Doha Derailed, A Pro gress Report on TRIPs and Access to Medicines, 27 August 2003 and Neither Expeditious, Nor A Solution: The WTO August 30th Decision Is Unworkable: An illustration through Canada's Jean Chrtien Pledge to Africa, Prepared for the XVI International AIDS Conference, Toronto, Au gust 2006, and Oxfam International, Patents versus Pa tients, Five years after the Doha Declaration, Oxfam Briefing Paper, November 2006[EB/OL]. [2013-04-15]. http:// www. msf. eh/fileadmin/user_upload/uploads/eommuniques/ images 2006/pdf/came_Neither_expeditious_nor_a_ solution_ -_August_30_and_the_JCPA single page. pdf.
  • 3Press Release, World Trade Org. Members OK Amendment to Make Health Flexibility Permanent, Dec. 6, 2005[EB/ OL]. [2013-04-15]. http//www, wto. org/english/news_ e/pres05_e/pr426 e. htm.
  • 4熊建军.WTO成员方认可《TRIPs协议修正案》的法经济学分析[J].西南政法大学学报,2010,12(6):129-135. 被引量：2
  • 5Trade Promotion Agreement, U. S.-Colom. Nov. 22, 2006 [EB/OL]. [2013-04-15]. http://www, ustr. gov/Trade A greements/Bilateral/Colombia_ FTA/Final Text/Section _ Index. html.
  • 6Legal Instruments Results of the Uruguay Round. A greement on Trade-Related Aspects of Intellectual Property Rights, Apr. 15, 1994, Marrakesh Agreement Establishing the World Trade Organization, Annex 1C[J]. International Legal Materials, 1994,33 : 81.
  • 7Lorna Dwyer. Patent Protection and Access to Medicine the Colombian and Peruvian Trade Promotion Agreements[J]. Law and Business Review of the Americas, 2007, 13.-825.
  • 8Standing Committee on the Law ofPatents. Draft Substan- tive Patent Law Treaty, WIPO, art. 2Doc. SCP/9/2, Mar. 3, 2003: IPR Text Proposed by U.S. to Thailand, Patents, sec. 2(b), 2006[EB/OL].[2013-04-15]. http://bilater als. org/artiele-print, php3? id article-36?7.
  • 9Free Trade Agreement. U.S.[EB/OL]. [2013- 04 -15].http grcement s/Bilateral/Singapore Index. html. Sing. , art. 16.7(6)(a),2003 ://www. ustr. gov/Trade_ A- FTA/Final Texts/Section.
  • 10Carlos Maria Correa. Protection Of Data Submitted For The Registration of Pharmaceuticals Implementing The Stand- ards Of The TRIPs Agreement, 2002-1-11 [EB/OL]. [ 2013-04-15]1, http://www. outhcentre. org/publications/ protection/protection, pdf.

二级参考文献26

  • 1Declaration on the TRIPS Agreement and Public Health[EB/OL]. (2001 - 11 - 14) [2010 -01 - 12]. http://www, wto. org/english/thewto _ e/minist _ e/min01 _ e/ mindecl_TRIPs_e, htm.
  • 2WTO. Members OK Amendment to Make Health Flexibility Permanent[ EB/JOL]. (2005 - 12 - 06 ) [ 2010 - 01 - 11 ]. http://www, wto, org/english/news_ e/pres05_e/ pr426_e, htm.
  • 3Frederick M. Abbott. WTO TRIPs Agreement and Its Implications for Access to Medicines in Developing Countries[ EB/OL ]. ( 2003 - 01 - 22 ) [ 2010 - 01 - 10 ]. http :// www. iprcommission, org/papers/pdfs/study_papers/sp2a ab- bott_study, pdf.
  • 4David Reiffen & Michael R. Ward. Generic Drug Industry Dynamics, FTC Bureau Economics Working Paper [EB/OL ]. [ 2010 - 01 - 05 ]. http ://www. ftc. gov/be/work- papersJindustrydynamicsreiffenwp, pdf.
  • 5Danzon, Patricia M. & Adrian Towse. Theory and Implementation of Differential Pricing for Pharmaceuticals [ G]//Keith E. Maskus & Jerome H. Reichman. International Public Goods and Transfer of Technology under a Globalized Intellectual Property Regime. Cambridge: Cambridge University Press, 2005:454.
  • 6Richard P. Rozek and Renee L. Rainey. Broad - based Compulsory Licensing of Pharmaceutical Technologies - Unsound Public Policy [ J ]. Journal of World Intellectual Property, Vol. 4, 2001:476-478..
  • 7Muge Olcay and Richard Laing. Pharmaceutical Tariffs : What Is Their Effect on Prices, Protection of Local Industry and Revenue Generation? [ EB/OL]. [2010- 01 - 02]. http://www, who. int/entity/intellectualproperty/stud- ies/TariffsOnEssentialMedicines, pdf.
  • 8Medecins Sans Frontieres. Untangling the Web of Price Reductions: A Pricing Guide for the Purchase of ARVs for Developing Countries [ EB/OL ]. [ 2010 - 01 - 02 3. http ://www. accessmed - msf. org/documents/untanglingtheweb% 209. pdf.
  • 9World Health Organization. Global Price Reporting Mechanism [ EB/OL ]. [ 2010 - 01 - 03]. http ://www. who. int/hiv/amds/gprm/err/index, html.
  • 10Haochen Sun. A Wider Access to Patented Drugs under the TRIPs Agreement [ J ]. Boston University International Law Journal, Vol. 101,2003 : 125.

共引文献1

科技和产业
2013年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部